The European Commission says it has concluded exploratory talks with CureVac to purchase a potential vaccine against COVID-19. This is following the positive steps with Sanofi-GSK on 31 July and Johnson and Johnson on 13 August and the signature of an Advance Purchase Agreement with AstraZeneca on 14 August. The envisaged contract with CureVac would…
You are here